Medicine’s Rong Xu finds semaglutide use associated with lower risk of Alzheimer’s diagnosis
Drugs like Ozempic and Wegovy are linked to a lower risk of Alzheimer’s disease, new study says
Fortune Magazine: Rong Xu, professor of medicine, discussed her new study of 1 million Americans with type 2 diabetes, which found that semaglutide users had a 40%–70% lower risk of a first Alzheimer’s diagnosis than those taking other diabetes drugs. Xu emphasized that the findings show an association, not causation, and require further research.
